Direct action antivirals are effective in the total eradication of HCV in renal transplants
<p><strong>Introduction</strong>: The main objective of our study was to analyze the effectiveness of antiviral treatment (conventional or with direct-acting antivirals (DAA)) for total eradication of Hepatitis C Virus (HCV) in kidney transplant (KT) recipients. DAA are known drugs...
Saved in:
Main Authors: | Teresa Olea (Author), Inmaculada Castillo (Author), Carlos Jiménez (Author), Javier Bartolomé (Author), María José Santana (Author), JA Quiroga (Author), Vicente Carreño (Author), Rafael Selgas (Author) |
---|---|
Format: | Book |
Published: |
Annals of Antivirals and Antiretrovirals - Peertechz Publications,
2019-07-22.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of HCV antiviral therapy on the Liver Transplantation Waiting-List assessed by mathematical models
by: Eleazar Chaib, et al.
Published: (2019) -
Chronic HCV Infection: Clinical Advances and Eradication Perspectives
Published: (2022) -
Epidemiological and clinical implications in Kidney Transplantation of occult Hepatitis C virus infection
by: Olea T1, et al.
Published: (2019) -
Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
by: Nicola Imperatore, et al.
Published: (2017) -
Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
by: Saima Mushtaq, et al.
Published: (2022)